{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:42:00Z","timestamp":1790664120633,"version":"4.1.0"},"reference-count":140,"publisher":"Portland Press Ltd.","issue":"4","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2011,8,1]]},"abstract":"<jats:p>ApoE4 (apolipoprotein E4) is the major known genetic risk factor for AD (Alzheimer's disease). In most clinical studies, apoE4 carriers account for 65\u201380% of all AD cases, highlighting the importance of apoE4 in AD pathogenesis. Emerging data suggest that apoE4, with its multiple cellular origins and multiple structural and biophysical properties, contributes to AD in multiple ways either independently or in combination with other factors, such as A\u03b2 (amyloid \u03b2-peptide) and tau. Many apoE mouse models have been established to study the mechanisms underlying the pathogenic actions of apoE4. These include transgenic mice expressing different apoE isoforms in neurons or astrocytes, those expressing neurotoxic apoE4 fragments in neurons and human apoE isoform knock-in mice. Since apoE is expressed in different types of cells, including astrocytes and neurons, and in brains under diverse physiological and\/or pathophysiological conditions, these apoE mouse models provide unique tools to study the cellular source-dependent roles of apoE isoforms in neurobiology and in the pathogenesis of AD. They also provide useful tools for discovery and development of drugs targeting apoE4's detrimental effects.<\/jats:p>","DOI":"10.1042\/bst0390924","type":"journal-article","created":{"date-parts":[[2011,7,26]],"date-time":"2011-07-26T12:05:03Z","timestamp":1311681903000},"page":"924-932","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Roles of apolipoprotein E4 (ApoE4) in the pathogenesis of Alzheimer's disease: lessons from ApoE mouse models"],"prefix":"10.1042","volume":"39","author":[{"given":"Yadong","family":"Huang","sequence":"first","affiliation":[{"name":"Gladstone Institute of Neurological Disease, University of California, San Francisco, San Francisco, CA 94158, U.S.A., Gladstone Institute of Cardiovascular Disease, University of California, San Francisco, CA 94158, U.S.A., Department of Pathology, University of California, San Francisco, CA 94158, U.S.A., and Department of Neurology, University of California, San Francisco, CA 94158, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2011,7,20]]},"reference":[{"key":"2021111719461999700_B1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/0896-6273(91)90052-2","article-title":"The molecular pathology of Alzheimer's disease","volume":"6","author":"Selkoe","year":"1991","journal-title":"Neuron"},{"key":"2021111719461999700_B2","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1172\/JCI0216783","article-title":"Deciphering the genesis and fate of amyloid \u03b2-protein yields novel therapies for Alzheimer disease","volume":"110","author":"Selkoe","year":"2002","journal-title":"J. Clin. Invest."},{"key":"2021111719461999700_B3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/S0166-2236(96)01030-2","article-title":"Amyloid, the presenilins and Alzheimer's disease","volume":"20","author":"Hardy","year":"1997","journal-title":"Trends Neurosci."},{"key":"2021111719461999700_B4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"key":"2021111719461999700_B5","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","article-title":"Gene dose of apolipoprotein E type\u00a04 allele and the risk of Alzheimer's disease in late onset families","volume":"261","author":"Corder","year":"1993","journal-title":"Science"},{"key":"2021111719461999700_B6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/jama.279.10.751","article-title":"The APOE-\u03f54 allele and the risk of Alzheimer disease among African Americans, whites, and Hispanics","volume":"279","author":"Tang","year":"1998","journal-title":"JAMA, J. Am. Med. Assoc."},{"key":"2021111719461999700_B7","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1212\/WNL.43.8.1467","article-title":"Association of apolipoprotein E allele \u03f54 with late-onset familial and sporadic Alzheimer's disease","volume":"43","author":"Saunders","year":"1993","journal-title":"Neurology"},{"key":"2021111719461999700_B8","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1126\/science.3283935","article-title":"Apolipoprotein E: cholesterol transport protein with expanding role in cell biology","volume":"240","author":"Mahley","year":"1988","journal-title":"Science"},{"key":"2021111719461999700_B9","first-page":"339","article-title":"Genetics of the apolipoprotein E system in man","volume":"32","author":"Utermann","year":"1980","journal-title":"Am. J. Hum. Genet."},{"key":"2021111719461999700_B10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1007\/BF00569216","article-title":"Genetic control of human apolipoprotein E polymorphism: comparison of one- and two-dimensional techniques of isoprotein analysis","volume":"60","author":"Utermann","year":"1982","journal-title":"Hum. Genet."},{"key":"2021111719461999700_B11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1021\/bi00507a059","article-title":"Human very low density lipoprotein apolipoprotein E isoprotein polymorphism is explained by genetic variation and posttranslational modification","volume":"20","author":"Zannis","year":"1981","journal-title":"Biochemistry"},{"key":"2021111719461999700_B12","first-page":"11","article-title":"Human apolipoprotein E isoprotein subclasses are genetically determined","volume":"33","author":"Zannis","year":"1981","journal-title":"Am. J. Hum. Genet."},{"key":"2021111719461999700_B13","doi-asserted-by":"crossref","first-page":"9077","DOI":"10.1016\/S0021-9258(19)52510-8","article-title":"Human E apoprotein heterogeneity: cysteine\u2013arginine interchanges in the amino acid sequence of the apo-E isoforms","volume":"256","author":"Weisgraber","year":"1981","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B14","doi-asserted-by":"crossref","first-page":"4171","DOI":"10.1016\/S0021-9258(18)34702-1","article-title":"Human apolipoprotein E: the complete amino acid sequence","volume":"257","author":"Rall","year":"1982","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B15","doi-asserted-by":"crossref","first-page":"4696","DOI":"10.1073\/pnas.79.15.4696","article-title":"Structural basis for receptor binding heterogeneity of apolipoprotein E from type\u00a0III hyperlipoproteinemic subjects","volume":"79","author":"Rall","year":"1982","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B16","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0065-3233(08)60642-7","article-title":"Apolipoprotein E: structure\u2013function relationships","volume":"45","author":"Weisgraber","year":"1994","journal-title":"Adv. Protein Chem."},{"key":"2021111719461999700_B17","doi-asserted-by":"crossref","first-page":"22358","DOI":"10.1016\/S0021-9258(17)31797-0","article-title":"Human apolipoprotein E: role of arginine 61 in mediating the lipoprotein preferences of the E3 and E4 isoforms","volume":"269","author":"Dong","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B18","doi-asserted-by":"crossref","first-page":"19053","DOI":"10.1074\/jbc.271.32.19053","article-title":"Human apolipoprotein E4 domain interaction: arginine 61 and glutamic acid 255 interact to direct the preference for very low density lipoproteins","volume":"271","author":"Dong","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B19","doi-asserted-by":"crossref","first-page":"25511","DOI":"10.1074\/jbc.M311256200","article-title":"Apolipoprotein E4 domain interaction occurs in living neuronal cells as determined by fluorescence resonance energy transfer","volume":"279","author":"Xu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B20","doi-asserted-by":"crossref","first-page":"18700","DOI":"10.1073\/pnas.0508693102","article-title":"Apolipoprotein (apo) E4 enhances amyloid \u03b2 peptide production in cultured neuronal cells: ApoE structure as a potential therapeutic target","volume":"102","author":"Ye","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B21","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1073\/pnas.0600549103","article-title":"Apolipoprotein E4: a causative factor and therapeutic target in neuropathology, including Alzheimer's disease","volume":"103","author":"Mahley","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B22","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.molmed.2010.04.004","article-title":"A\u03b2-independent roles of apolipoprotein E4 in the pathogenesis of Alzheimer's disease","volume":"16","author":"Huang","year":"2010","journal-title":"Trends Mol. Med."},{"key":"2021111719461999700_B23","doi-asserted-by":"crossref","first-page":"11587","DOI":"10.1073\/pnas.201279298","article-title":"Introduction of human apolipoprotein E4 \u2018domain interaction\u2019 into mouse apolipoprotein E","volume":"98","author":"Raffa\u00ef","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1172\/JCI112130","article-title":"Apolipoprotein E associated with astrocytic glia of the central nervous system and with nonmyelinating glia of the peripheral nervous system","volume":"76","author":"Boyles","year":"1985","journal-title":"J. Clin. Invest."},{"key":"2021111719461999700_B25","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0169-328X(91)90111-A","article-title":"Astrocytic apolipoprotein E mRNA and GFAP mRNA in hippocampus after entorhinal cortex lesioning","volume":"11","author":"Poirier","year":"1991","journal-title":"Mol. Brain Res."},{"key":"2021111719461999700_B26","doi-asserted-by":"crossref","first-page":"31567","DOI":"10.1074\/jbc.M005468200","article-title":"Duplicated downstream enhancers control expression of the human apolipoprotein E gene in macrophages and adipose tissue","volume":"275","author":"Shih","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B27","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1523\/JNEUROSCI.21-03-00812.2001","article-title":"Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain","volume":"21","author":"Grehan","year":"2001","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B28","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/(SICI)1098-2396(19990315)31:4<278::AID-SYN5>3.0.CO;2-0","article-title":"Glial gene expression during aging in rat striatum and in long-term responses to 6-OHDA lesions","volume":"31","author":"Pasinetti","year":"1999","journal-title":"Synapse"},{"key":"2021111719461999700_B29","doi-asserted-by":"crossref","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","article-title":"Profile and regulation of apolipoprotein E (apoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the apoE locus","volume":"26","author":"Xu","year":"2006","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B30","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.0953-816x.2001.01643.x","article-title":"Astrocytes down-regulate neuronal \u03b2-amyloid precursor protein expression and modify its processing in an apolipoprotein E isoform-specific manner","volume":"14","author":"Vincent","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"2021111719461999700_B31","doi-asserted-by":"crossref","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","article-title":"Isoform-specific binding of apolipoprotein E to \u03b2-amyloid","volume":"269","author":"LaDu","year":"1994","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B32","doi-asserted-by":"crossref","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","article-title":"Purification of apolipoprotein E attenuates isoform-specific binding to \u03b2-amyloid","volume":"270","author":"LaDu","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B33","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1073\/pnas.050004797","article-title":"Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease","volume":"97","author":"Holtzman","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B34","doi-asserted-by":"crossref","first-page":"15233","DOI":"10.1073\/pnas.96.26.15233","article-title":"Apolipoprotein E is essential for amyloid deposition in the APPV717F transgenic mouse model of Alzheimer's disease","volume":"96","author":"Bales","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B35","doi-asserted-by":"crossref","first-page":"9480","DOI":"10.1073\/pnas.92.21.9480","article-title":"Low density lipoprotein receptor-related protein mediates apolipoprotein E-dependent neurite outgrowth in a central nervous system-derived neuronal cell line","volume":"92","author":"Holtzman","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B36","doi-asserted-by":"crossref","first-page":"27273","DOI":"10.1074\/jbc.M109.014464","article-title":"Apolipoprotein E4 domain interaction induces endoplasmic reticulum stress and impairs astrocyte function","volume":"284","author":"Zhong","year":"2009","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B37","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2353\/ajpath.2010.090973","article-title":"Cellular source of apolipoprotein E4 determines neuronal susceptibility to excitotoxic injury in transgenic mice","volume":"177","author":"Buttini","year":"2010","journal-title":"Am. J. Pathol."},{"key":"2021111719461999700_B38","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/j.1749-6632.1996.tb34415.x","article-title":"Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease","volume":"777","author":"Beffert","year":"1996","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021111719461999700_B39","doi-asserted-by":"crossref","first-page":"11923","DOI":"10.1016\/S0021-9258(19)68494-2","article-title":"Monoclonal antibodies to the low density lipoprotein receptor as probes for study of receptor-mediated endocytosis and the genetics of familial hypercholesterolemia","volume":"256","author":"Beisiegel","year":"1981","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B40","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1128\/jvi.65.9.4759-4768.1991","article-title":"Neuropathological changes in scrapie and Alzheimer's disease are associated with increased expression of apolipoprotein E and cathepsin D in astrocytes","volume":"65","author":"Diedrich","year":"1991","journal-title":"J. Virol."},{"key":"2021111719461999700_B41","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00005072-199409000-00013","article-title":"Apolipoprotein E is localized to the cytoplasm of human cortical neurons: a light and electron microscopic study","volume":"53","author":"Han","year":"1994","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021111719461999700_B42","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1097\/00001756-199607290-00008","article-title":"Expression of apolipoprotein E in normal and diverse neurodegenerative disease brain","volume":"7","author":"Bao","year":"1996","journal-title":"NeuroReport"},{"key":"2021111719461999700_B43","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/00005072-199603000-00013","article-title":"Neurons of the human frontal cortex display apolipoprotein E immunoreactivity: implications for Alzheimer's disease","volume":"55","author":"Metzger","year":"1996","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021111719461999700_B44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1006\/nbdi.1998.0213","article-title":"Sialylated human apolipoprotein E (apoEs) is preferentially associated with neuron-enriched cultures from APOE transgenic mice","volume":"6","author":"Xu","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"2021111719461999700_B45","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0002-9440(10)65305-9","article-title":"Specific regional transcription of apolipoprotein E in human brain neurons","volume":"154","author":"Xu","year":"1999","journal-title":"Am. J. Pathol."},{"key":"2021111719461999700_B46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(98)00247-X","article-title":"Regionally specific neuronal expression of human APOE gene in transgenic mice","volume":"246","author":"Xu","year":"1998","journal-title":"Neurosci. Lett."},{"key":"2021111719461999700_B47","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/nbdi.1996.0023","article-title":"Human apolipoprotein E2, E3, and E4 isoform-specific transgenic mice: human-like pattern of glial and neuronal immunoreactivity in central nervous system not observed in wild-type mice","volume":"3","author":"Xu","year":"1996","journal-title":"Neurobiol. Dis."},{"key":"2021111719461999700_B48","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1006\/nbdi.1999.0251","article-title":"Apolipoprotein E expression by neurons surviving excitotoxic stress","volume":"6","author":"Boschert","year":"1999","journal-title":"Neurobiol. Dis."},{"key":"2021111719461999700_B49","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/01.STR.0000064320.73388.C6","article-title":"Increased expression of neuronal apolipoprotein E in human brain with cerebral infarction","volume":"34","author":"Aoki","year":"2003","journal-title":"Stroke"},{"key":"2021111719461999700_B50","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/1098-1136(20010315)33:4<298::AID-GLIA1028>3.0.CO;2-N","article-title":"Synthesis and processing of apolipoprotein E in human brain cultures","volume":"33","author":"Dekroon","year":"2001","journal-title":"Glia"},{"key":"2021111719461999700_B51","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1006\/nbdi.1997.0155","article-title":"ApoE synthesis in human neuroblastoma cells","volume":"4","author":"Dupont-Wallois","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"2021111719461999700_B52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/exnr.2000.7510","article-title":"Synthesis and regulation of apolipoprotein E during the differentiation of human neuronal precursor NT2\/D1 cells into postmitotic neurons","volume":"166","author":"Ferreira","year":"2000","journal-title":"Exp. Neurol."},{"key":"2021111719461999700_B53","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0304-3940(99)00167-6","article-title":"Synthesis of apolipoprotein E (apoE) mRNA by human neuronal-type SK N SH-SY 5Y cells and its regulation by nerve growth factor and apoE","volume":"265","author":"Souli\u00e9","year":"1999","journal-title":"Neurosci. Lett."},{"key":"2021111719461999700_B54","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1074\/jbc.M309475200","article-title":"Astroglial regulation of apolipoprotein E expression in neuronal cells: implications for Alzheimer's disease","volume":"279","author":"Harris","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B55","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1523\/JNEUROSCI.3253-07.2008","article-title":"Intron-3 retention\/splicing controls neuronal expression of apolipoprotein E in the CNS","volume":"28","author":"Xu","year":"2008","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B56","doi-asserted-by":"crossref","first-page":"8838","DOI":"10.1073\/pnas.151254698","article-title":"Apolipoprotein E fragments present in Alzheimer's disease brains induce neurofibrillary tangle-like intracellular inclusions in neurons","volume":"98","author":"Huang","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B57","doi-asserted-by":"crossref","first-page":"10966","DOI":"10.1073\/pnas.1434398100","article-title":"Carboxyl-terminal-truncated apolipoprotein E4 causes Alzheimer's disease-like neurodegeneration and behavioral deficits in transgenic mice","volume":"100","author":"Harris","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B58","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1523\/JNEUROSCI.4315-03.2004","article-title":"Neuron-specific apolipoprotein E4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice","volume":"24","author":"Brecht","year":"2004","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B59","doi-asserted-by":"crossref","first-page":"18694","DOI":"10.1073\/pnas.0508254102","article-title":"Lipid- and receptor-binding regions of apolipoprotein E4 fragments act in concert to cause mitochondrial dysfunction and neurotoxicity","volume":"102","author":"Chang","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B60","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0002-9440(10)64963-2","article-title":"Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice","volume":"156","author":"Tesseur","year":"2000","journal-title":"Am. J. Pathol."},{"key":"2021111719461999700_B61","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/S0002-9440(10)64788-8","article-title":"Prominent axonopathy and disruption of axonal transport in transgenic mice expressing human apolipoprotein E4 in neurons of brain and spinal cord","volume":"157","author":"Tesseur","year":"2000","journal-title":"Am. J. Pathol."},{"key":"2021111719461999700_B62","doi-asserted-by":"crossref","first-page":"44795","DOI":"10.1074\/jbc.M408127200","article-title":"Increased tau phosphorylation in apolipoprotein E4 transgenic mice is associated with activation of extracellular signal-regulated kinase: modulation by zinc","volume":"279","author":"Harris","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B63","doi-asserted-by":"crossref","first-page":"21821","DOI":"10.1074\/jbc.M112109200","article-title":"Apolipoprotein E4 potentiates amyloid \u03b2 peptide-induced lysosomal leakage and apoptosis in neuronal cells","volume":"277","author":"Ji","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B64","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1523\/JNEUROSCI.19-12-04867.1999","article-title":"Expression of human apolipoprotein E3 or E4 in the brains of Apoe\u2212\/\u2212 mice: isoform-specific effects on neurodegeneration","volume":"19","author":"Buttini","year":"1999","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B65","doi-asserted-by":"crossref","first-page":"10539","DOI":"10.1523\/JNEUROSCI.22-24-10539.2002","article-title":"Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid \u03b2 peptides but not on plaque formation","volume":"22","author":"Buttini","year":"2002","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B66","doi-asserted-by":"crossref","first-page":"5204","DOI":"10.1523\/JNEUROSCI.22-12-05204.2002","article-title":"Androgens protect against apolipoprotein E4-induced cognitive deficits","volume":"22","author":"Raber","year":"2002","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B67","doi-asserted-by":"crossref","first-page":"10914","DOI":"10.1073\/pnas.95.18.10914","article-title":"Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females","volume":"95","author":"Raber","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B68","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/35006165","article-title":"Apolipoprotein E and cognitive performance","volume":"404","author":"Raber","year":"2000","journal-title":"Nature"},{"key":"2021111719461999700_B69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1097\/00041433-199906000-00003","article-title":"Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond","volume":"10","author":"Mahley","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"2021111719461999700_B70","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1006\/nbdi.1997.0161","article-title":"Apolipoprotein E, a gene with complex biological interactions in the aging brain","volume":"4","author":"Roses","year":"1997","journal-title":"Neurobiol. Dis."},{"key":"2021111719461999700_B71","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1385\/JMN:23:3:189","article-title":"Apolipoprotein E: diversity of cellular origins, structural and biophysical properties, and effects in Alzheimer's disease","volume":"23","author":"Huang","year":"2004","journal-title":"J. Mol. Neurosci."},{"key":"2021111719461999700_B72","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"key":"2021111719461999700_B73","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0006-8993(91)91092-F","article-title":"Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt\u2013Jakob disease","volume":"541","author":"Namba","year":"1991","journal-title":"Brain Res."},{"key":"2021111719461999700_B74","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0304-3940(92)90444-C","article-title":"Apolipoprotein E: a pathological chaperone protein in patients with cerebral and systemic amyloid","volume":"135","author":"Wisniewski","year":"1992","journal-title":"Neurosci. Lett."},{"key":"2021111719461999700_B75","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1073\/pnas.90.5.1977","article-title":"Apolipoprotein E: high-avidity bindingto \u03b2-amyloid and increased frequency of type\u00a04 allele in late-onset familial Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B76","doi-asserted-by":"crossref","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","article-title":"Binding of human apolipoprotein E to synthetic amyloid \u03b2 peptide: isoform-specific effects and implications for late-onset Alzheimer disease","volume":"90","author":"Strittmatter","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B77","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1093\/jnen\/60.4.342","article-title":"Quantitation of apoE domains in Alzheimer disease brain suggests a role for apoE in A\u03b2 aggregation","volume":"60","author":"Cho","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2021111719461999700_B78","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1021\/bi982437d","article-title":"Differential effects of apolipoprotein E isoforms on metal-induced aggregation of A\u03b2 using physiological concentrations","volume":"38","author":"Moir","year":"1999","journal-title":"Biochemistry"},{"key":"2021111719461999700_B79","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1523\/JNEUROSCI.18-01-00195.1998","article-title":"Isoform-specific effect of apolipoprotein E on cell survival and \u03b2-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures","volume":"18","author":"Jord\u00e1n","year":"1998","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B80","doi-asserted-by":"crossref","first-page":"4236","DOI":"10.1073\/pnas.1018381108","article-title":"C-terminal-truncated apolipoprotein (apo) E4 inefficiently clears amyloid-\u03b2 (A\u03b2) and acts in concert with A\u03b2 to elicit neuronal and behavioral deficits in mice","volume":"8","author":"Bien-Ly","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B81","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0409072102","article-title":"Gene delivery of human apolipoprotein E alters brain A\u03b2 burden in a mouse model of Alzheimer's disease","volume":"102","author":"Dodart","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1038\/nm1058","article-title":"Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-\u03b2 peptides","volume":"10","author":"Koistinaho","year":"2004","journal-title":"Nat. Med."},{"key":"2021111719461999700_B83","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.neurobiolaging.2003.12.011","article-title":"Cognitive impairment in PDAPP mice depends on apoE and ACT-catalyzed amyloid formation","volume":"25","author":"Nilsson","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"2021111719461999700_B84","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2353\/ajpath.2006.050752","article-title":"Neuronal or glial expression of human apolipoprotein E4 affects parenchymal and vascular amyloid pathology differentially in different brain regions of double- and triple-transgenic mice","volume":"168","author":"Van\u00a0Dooren","year":"2006","journal-title":"Am. J. Pathol."},{"key":"2021111719461999700_B85","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/hmg\/10.22.2525","article-title":"Hyper-expression of human apolipoprotein E4 in astroglia and neurons does not enhance amyloid deposition in transgenic mice","volume":"10","author":"Lesuisse","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"2021111719461999700_B86","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1002\/1531-8249(200006)47:6<739::AID-ANA6>3.0.CO;2-8","article-title":"Apolipoprotein E facilitates neuritic and cerebrovascular plaque formation in an Alzheimer's disease model","volume":"47","author":"Holtzman","year":"2000","journal-title":"Ann. Neurol."},{"key":"2021111719461999700_B87","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1006\/exnr.2001.7715","article-title":"Behavioral phenotyping of GFAP-apoE3 and -apoE4 transgenic mice: ApoE4 mice show profound working memory impairments in the absence of Alzheimer's-like neuropathology","volume":"170","author":"Hartman","year":"2001","journal-title":"Exp. Neurol."},{"key":"2021111719461999700_B88","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","article-title":"Apolipoprotein E4 causes age- and Tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice","volume":"30","author":"Andrews-Zwilling","year":"2010","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B89","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1097\/00001756-200205070-00026","article-title":"Truncated apoE forms tangle-like structures in a neuronal cell line","volume":"13","author":"Ljungberg","year":"2002","journal-title":"NeuroReport"},{"key":"2021111719461999700_B90","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1326-4-35","article-title":"Apolipoprotein E4 (1\u2013272) fragment is associated with mitochondrial proteins and affects mitochondrial function in neuronal cells","volume":"4","author":"Nakamura","year":"2009","journal-title":"Mol. Neurodegener."},{"key":"2021111719461999700_B91","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(88)90263-2","article-title":"Cellular uptake of the tat protein from human immunodeficiency virus","volume":"55","author":"Frankel","year":"1988","journal-title":"Cell"},{"key":"2021111719461999700_B92","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/0092-8674(88)90262-0","article-title":"Autonomous functional domains of chemically synthesized human immunodeficiency virus tat trans-activator protein","volume":"55","author":"Green","year":"1988","journal-title":"Cell"},{"key":"2021111719461999700_B93","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1021\/bi060023b","article-title":"Effect of carboxyl-terminal truncation on structure and lipid interaction of human apolipoprotein E4","volume":"45","author":"Tanaka","year":"2006","journal-title":"Biochemistry"},{"key":"2021111719461999700_B94","doi-asserted-by":"crossref","first-page":"13333","DOI":"10.1074\/jbc.M511077200","article-title":"Structural and functional variations in human apolipoprotein E3 and E4","volume":"281","author":"Chou","year":"2006","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B95","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1161\/01.ATV.8.3.288","article-title":"Apolipoprotein E-binding proteins isolated from dog and human liver","volume":"8","author":"Beisiegel","year":"1988","journal-title":"Arteriosclerosis"},{"key":"2021111719461999700_B96","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0022-2275(20)42343-0","article-title":"Apolipoprotein E localization in rat hepatocytes by immunogold labeling of cryothin sections","volume":"31","author":"Hamilton","year":"1990","journal-title":"J. Lipid Res."},{"key":"2021111719461999700_B97","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1749-6632.1999.tb07825.x","article-title":"Use of cytoplasmic hybrid cell lines for elucidating the role of mitochondrial dysfunction in Alzheimer's disease and Parkinson's disease","volume":"893","author":"Ghosh","year":"1999","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021111719461999700_B98","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/ars.2005.7.1101","article-title":"Differentiated Alzheimer's disease transmitochondrial cybrid cell lines exhibit reduced organelle movement","volume":"7","author":"Trimmer","year":"2005","journal-title":"Antioxid. Redox Signal."},{"key":"2021111719461999700_B99","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1006\/bbrc.2000.2923","article-title":"Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population","volume":"273","author":"Kamino","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021111719461999700_B100","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1523\/JNEUROSCI.21-09-03017.2001","article-title":"Mitochondrial abnormalities in Alzheimer's disease","volume":"21","author":"Hirai","year":"2001","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B101","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/1531-8249(200009)48:3<297::AID-ANA3>3.0.CO;2-Z","article-title":"Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype","volume":"48","author":"Gibson","year":"2000","journal-title":"Ann. Neurol."},{"key":"2021111719461999700_B102","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1073\/pnas.2635903100","article-title":"Functional brain abnormalities in young adults at genetic risk for late-onset Alzheimer's dementia","volume":"101","author":"Reiman","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B103","doi-asserted-by":"crossref","first-page":"8299","DOI":"10.1073\/pnas.0500579102","article-title":"Correlations between apolipoprotein E \u03f54 gene dose and brain-imaging measurements of regional hypometabolism","volume":"102","author":"Reiman","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B104","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1212\/01.WNL.0000148478.39691.D3","article-title":"Cerebral glucose metabolism in patients with AD and different APOE genotypes","volume":"64","author":"Drzezga","year":"2005","journal-title":"Neurology"},{"key":"2021111719461999700_B105","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1001\/archneur.58.3.360","article-title":"Age-related memory decline: current concepts and future directions","volume":"58","author":"Small","year":"2001","journal-title":"Arch. Neurol."},{"key":"2021111719461999700_B106","doi-asserted-by":"crossref","first-page":"7181","DOI":"10.1073\/pnas.0400285101","article-title":"Imaging correlates of brain function in monkeys and rats isolates a hippocampal subregion differentially vulnerable to aging","volume":"101","author":"Small","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B107","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/jnnp.2003.030882","article-title":"Metabolic interaction between apoE genotype and onset age in Alzheimer's disease: implications for brain reserve","volume":"76","author":"Mosconi","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111719461999700_B108","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1136\/jnnp.2003.014993","article-title":"Brain metabolic decreases related to the dose of the apoE e4 allele in Alzheimer's disease","volume":"75","author":"Mosconi","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111719461999700_B109","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1212\/01.WNL.0000147469.18313.3B","article-title":"MCI conversion to dementia and the APOE genotype: a prediction study with FDG-PET","volume":"63","author":"Mosconi","year":"2004","journal-title":"Neurology"},{"key":"2021111719461999700_B110","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.pscychresns.2003.12.005","article-title":"Age and apoE genotype interaction in Alzheimer's disease: an FDG-PET study","volume":"130","author":"Mosconi","year":"2004","journal-title":"Psychiatry Res."},{"key":"2021111719461999700_B111","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1212\/WNL.58.5.743","article-title":"The effect of APOE \u03f54 allele on cerebral glucose metabolism in AD is a function of age at onset","volume":"58","author":"Hirono","year":"2002","journal-title":"Neurology"},{"key":"2021111719461999700_B112","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1136\/jnnp.2004.053645","article-title":"APOE related alterations in cerebral activation even at college age","volume":"76","author":"Scarmeas","year":"2005","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2021111719461999700_B113","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1126\/science.8171342","article-title":"Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro","volume":"264","author":"Nathan","year":"1994","journal-title":"Science"},{"key":"2021111719461999700_B114","doi-asserted-by":"crossref","first-page":"19791","DOI":"10.1074\/jbc.270.34.19791","article-title":"The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization","volume":"270","author":"Nathan","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B115","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0022-2275(20)41390-2","article-title":"Effects of apolipoproteinE, \u03b2-very low density lipoproteins, and cholesterol on the extension of neurites by rabbit dorsal root ganglion neurons in vitro","volume":"33","author":"Handelmann","year":"1992","journal-title":"J. Lipid Res."},{"key":"2021111719461999700_B116","doi-asserted-by":"crossref","first-page":"4206","DOI":"10.1074\/jbc.273.7.4206","article-title":"A minimally lipidated form of cell-derived apolipoprotein E exhibits isoform-specific stimulation of neurite outgrowth in the absence of exogenous lipids or lipoproteins","volume":"273","author":"DeMattos","year":"1998","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B117","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/S0022-2275(20)31622-9","article-title":"Biochemical analysis of cell-derived apoE3 particles active in stimulating neurite outgrowth","volume":"42","author":"DeMattos","year":"2001","journal-title":"J. Lipid Res."},{"key":"2021111719461999700_B118","doi-asserted-by":"crossref","first-page":"30121","DOI":"10.1074\/jbc.271.47.30121","article-title":"Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein","volume":"271","author":"Fagan","year":"1996","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B119","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1523\/JNEUROSCI.18-09-03261.1998","article-title":"Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins","volume":"18","author":"Sun","year":"1998","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B120","doi-asserted-by":"crossref","first-page":"27063","DOI":"10.1074\/jbc.270.45.27063","article-title":"Stable expression and secretion of apolipoproteins E3 and E4 in mouse neuroblastoma cells produces differential effects on neurite outgrowth","volume":"270","author":"Bellosta","year":"1995","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B121","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jnr.10221","article-title":"Defective neuronal sprouting by human apolipoprotein E4 is a gain-of-negative function","volume":"68","author":"Teter","year":"2002","journal-title":"J. Neurosci. Res."},{"key":"2021111719461999700_B122","doi-asserted-by":"crossref","first-page":"34948","DOI":"10.1074\/jbc.M401055200","article-title":"Apolipoprotein E receptors mediate neurite outgrowth through activation of p44\/42 mitogen-activated protein kinase in primary neurons","volume":"279","author":"Qiu","year":"2004","journal-title":"J. Biol. Chem."},{"key":"2021111719461999700_B123","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.neuroscience.2003.08.007","article-title":"Apolipoprotein E isoform-specific regulation of dendritic spine morphology in apolipoprotein E transgenic mice and Alzheimer's disease patients","volume":"122","author":"Ji","year":"2003","journal-title":"Neuroscience"},{"key":"2021111719461999700_B124","doi-asserted-by":"crossref","first-page":"15317","DOI":"10.1523\/JNEUROSCI.4026-09.2009","article-title":"ApoE4 decreases spine density and dendritic complexity in cortical neurons in vivo","volume":"29","author":"Dumanis","year":"2009","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B125","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1073\/pnas.0709906104","article-title":"Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons","volume":"105","author":"Brodbeck","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021111719461999700_B126","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.stem.2009.10.015","article-title":"GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice","volume":"5","author":"Li","year":"2009","journal-title":"Cell Stem Cell"},{"key":"2021111719461999700_B127","first-page":"202","article-title":"Environmental enrichment stimulates neurogenesis in apolipoprotein E3 and neuronal apoptosis in apolipoprotein E4 transgenic mice","volume":"100","author":"Levi","year":"2007","journal-title":"J. Neurosci."},{"key":"2021111719461999700_B128","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1172\/JCI117407","article-title":"Apolipoprotein E associates with \u03b2 amyloid peptide of Alzheimer's disease to form novel monofibrils: isoform apoE4 associates more efficiently than apoE3","volume":"94","author":"Sanan","year":"1994","journal-title":"J. Clin. Invest."},{"key":"2021111719461999700_B129","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/372092a0","article-title":"Amyloid-associated proteins \u03b11-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer \u03b2-protein into filaments","volume":"372","author":"Ma","year":"1994","journal-title":"Nature"},{"key":"2021111719461999700_B130","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1172\/JCI10498","article-title":"Clearance of Alzheimer's amyloid-\u03b21\u201340 peptide from brain by LDL receptor-related protein-1 at the blood\u2013brain barrier","volume":"106","author":"Shibata","year":"2000","journal-title":"J. Clin. Invest."},{"key":"2021111719461999700_B131","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1046\/j.1471-4159.1997.69051995.x","article-title":"Isoform-specific effects of apolipoproteins E2, E3, and E4 on cerebral capillary sequestration and blood\u2013brain barrier transport of circulating Alzheimer's amyloid \u03b2","volume":"69","author":"Martel","year":"1997","journal-title":"J. Neurochem."},{"key":"2021111719461999700_B132","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s004010000263","article-title":"Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid \u03b2-peptide deposition in homozygous APPV717F transgenic mice","volume":"100","author":"Irizarry","year":"2000","journal-title":"Acta Neuropathol."},{"key":"2021111719461999700_B133","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.neuron.2009.06.026","article-title":"The role of apolipoprotein E in Alzheimer's disease","volume":"63","author":"Kim","year":"2009","journal-title":"Neuron"},{"key":"2021111719461999700_B134","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/ng0996-55","article-title":"Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and \u03b2-amyloid peptides","volume":"14","author":"Miyata","year":"1996","journal-title":"Nat. Genet."},{"key":"2021111719461999700_B135","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0006-8993(01)03228-0","article-title":"Apolipoprotein E modulates Alzheimer's A\u03b21\u201342-induced oxidative damage to synaptosomes in an allele-specific manner","volume":"924","author":"Lauderback","year":"2002","journal-title":"Brain Res."},{"key":"2021111719461999700_B136","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/00001756-200203250-00021","article-title":"Oxidative protein damage in cells engaged in \u03b2-amyloidosis is related to apoE genotype","volume":"13","author":"Mazur-Kolecka","year":"2002","journal-title":"NeuroReport"},{"key":"2021111719461999700_B137","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/35036221","article-title":"Apolipoprotein E receptors: linking brain development and Alzheimer's disease","volume":"1","author":"Herz","year":"2000","journal-title":"Nat. Rev. Neurosci."},{"key":"2021111719461999700_B138","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.neuroscience.2003.08.017","article-title":"ApoE isoforms affect neuronal N-methyl-D-aspartate calcium responses and toxicity via receptor-mediated processes","volume":"122","author":"Qiu","year":"2003","journal-title":"Neuroscience"},{"key":"2021111719461999700_B139","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1471-4159.2004.03007.x","article-title":"Multiple pathways of apolipoprotein E signaling in primary neurons","volume":"93","author":"Hoe","year":"2005","journal-title":"J. Neurochem."},{"key":"2021111719461999700_B140","doi-asserted-by":"crossref","first-page":"11183","DOI":"10.1073\/pnas.91.23.11183","article-title":"Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease","volume":"91","author":"Strittmatter","year":"1994","journal-title":"Proc. Natl. Acad. Sci. U.S.A."}],"container-title":["Biochemical Society Transactions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/924\/549087\/bst0390924.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article-pdf\/39\/4\/924\/549087\/bst0390924.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,17]],"date-time":"2021-11-17T22:23:11Z","timestamp":1637187791000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/biochemsoctrans\/article\/39\/4\/924\/65285\/Roles-of-apolipoprotein-E4-ApoE4-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,20]]},"references-count":140,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2011,7,20]]},"published-print":{"date-parts":[[2011,8,1]]}},"URL":"https:\/\/doi.org\/10.1042\/bst0390924","relation":{},"ISSN":["0300-5127","1470-8752"],"issn-type":[{"value":"0300-5127","type":"print"},{"value":"1470-8752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,20]]}}}